You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 5, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
M Grazia Cotticelli1, Fabio Acquaviva2, Shujuan Xia3
1Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA The Penn Medicine/CHOP Center of Excellence for Friedreich's Ataxia Research, Philadelphia, PA, USA.
Researchers screened Friedreich ataxia (FRDA) cells and found two short-hairpin RNAs (shRNAs) that improve cell growth. One shRNA successfully increased frataxin protein levels, offering a potential therapeutic avenue for FRDA.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: